Status:
COMPLETED
SENSING-AI Cohort for Long COVID Patients
Lead Sponsor:
Adhera Health, Inc.
Collaborating Sponsors:
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Conditions:
Post-acute COVID-19 Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
The prospective study will focus on the collection of biometric and psychometric data from a limited population for 1 month with the aim of complementing the SENSING-AI retrospective cohort.
Detailed Description
The stratification of the risk of complications related to persistent COVID symptoms both physiological and psychological in a personalized way would optimize the cost-effectiveness model for the mana...
Eligibility Criteria
Inclusion
- Legal adults
- With a long COVID-19 diagnose in the last year
- Reporting any of these symptoms:
- Fatigue
- Dyspnea
- Shortness of breath
- Anxiety
- Stress
- Depression
- Conduct disorder
- Sleep disorder
Exclusion
- Hospital admission during follow-up due to pathology not related to COVID-19
- Patients without digital literacy or who cannot use the mobile application.
- Known severe psychiatric illness or cognitive impairment
- Being pregnant (or suspected to be pregnant)
- Discharged after hospital admission due to COVID-19
Key Trial Info
Start Date :
January 18 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 28 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05204615
Start Date
January 18 2022
End Date
April 28 2022
Last Update
January 5 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
IDIAP Jordi Gol
Barcelona, Spain, 08007
2
Primary Care Aljarafe-Sevilla Norte
Seville, Spain, 41927